Functional Constipation: Pathophysiology, evaluation, and management
Alimentary Pharmacology & Therapeutics · 2024-07 · 60 (S1)
DOI: 10.1111/apt.17852 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Alimentary Pharmacology & Therapeutics, online erschienen am 25.06.2024. Verfasst von Alexandra Kilgore und 1 weiteren Autor:innen. Beteiligte Einrichtung: Digestive Health Institute, Children's Hospital Colorado, Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado, USA. Hauptthemen laut MEDLINE: Constipation. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 65 Literaturangaben.
Abstract (Originalsprache)
Background
Functional constipation (FC), a disorder of the gut–brain interaction of multifactorial pathophysiology that is prevalent in paediatrics. It is associated with bothersome symptoms, increased healthcare costs, disgruntled caregivers and impaired health‐related quality of life. Paediatric FC is a clinical diagnosis based on the Rome IV criteria and is characterised by decreased bowel movement frequency and/or hard, painful stools and can be complicated by retentive faecal incontinence. Stressful life events, difficult temperaments and emotional and behavioural challenges have been implicated in increasing risk of developing paediatric FC.
Aims
To provide current concepts in pathophysiology, evaluation and management of paediatric FC.
Methods
We reviewed pertinent literature after a comprehensive search utilising PubMed with keywords FC, chronic childhood constipation and paediatric FC.
Results
In the last decade, advances in our understanding of paediatric FC have changed the landscape of diagnosing and treating this disorder. Although polyethylene glycol is the first‐line treatment for maintenance of FC, the armamentarium of therapeutics has expanded including the first Food and Drug Administration‐ agent, linaclotide, for children 6–17 years of age in conjunction with more emphasis on behavioural and physical therapy interventions.
Conclusions
Treatment approach to paediatric FC should be individualised and integrated focusing on parental education, lifestyle and behavioural modifications, and pharmacological therapy to maximise therapeutic success. This review highlights advances in pathophysiology, diagnosis and treatment of FC in children.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Digestive Health Institute, Children's Hospital Colorado, Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado, USA.
- Division of Pediatric Gastroenterology, Hepatology and Nutrition, Columbia University Medical Center, Columbia University Vagelos College of Physicians and Surgeons/NewYork-Presbyterian Morgan Stanley Children's Hospita…
ORCID-Profile: Julie Khlevner
Zitieren
APA
Kilgore, A., & Khlevner, J. (2024). Functional Constipation: Pathophysiology, evaluation, and management. Alimentary Pharmacology & Therapeutics, 60(S1). https://doi.org/10.1111/apt.17852
Vancouver
Kilgore A, Khlevner J. Functional Constipation: Pathophysiology, evaluation, and management. Alimentary Pharmacology & Therapeutics. 2024;60(S1). doi:10.1111/apt.17852
BibTeX
@article{Kilgore2024,
author = {Kilgore, Alexandra and Khlevner, Julie},
title = {Functional Constipation: Pathophysiology, evaluation, and management},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2024},
volume = {60},
number = {S1},
doi = {10.1111/apt.17852}
}
EUVIMED